Desmoglein I Antibody (Vesiculobullous Disorders)

Desmoglein I Antibody (Vesiculobullous Disorders) test is a valuable tool for screening patients suspected of having a group of autoimmune blistering skin diseases called vesiculobullous disorders characterized by the formation of blisters (bullae) and vesicles, which are fluid-filled lesions, particularly pemphigus. This test detects the presence of antibodies targeting Desmoglein I, a protein crucial for holding skin cells together. These antibodies are associated with autoimmune blistering disorders, which cause the skin or mucous membranes to develop painful blisters, erosions, and sores. This test helps doctors differentiate between different types of vesiculobullous disorders and guide appropriate treatment decisions. This test also helps monitor disease activity and response to treatment in patients with autoimmune blistering disorders. This test may be recommended if you have symptoms such as painful blisters, erosions, or sores on the skin or mucous membranes if there is a family history of autoimmune blistering disorders, if an existing diagnosis of an autoimmune blistering disorder, and if there is a need for monitoring or treatment assessment.

Please note: This is an outsourced test. The sample for this test is collected by TATA 1MG and processed at a NABL accredited partnered lab.